Arrowhead Pharmaceuticals Inc banner

Wall St Price Targets

HDP1 Price Forecast
Based on 17 analysts

+150% Upside
from €40.31 today

Arrowhead Pharmaceuticals Inc (HDP1)’s 12-month stock price forecast through November 2027 has a consensus target of €100.75, implying 150% upside. The forecast is based on price targets from 17 Wall Street analysts.

HDP1 Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for HDP1 yet.

Arrowhead Pharmaceuticals Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is HDP1's stock price target?
Price Target
100.75 EUR

According to Wall Street analysts, the average 1-year price target for HDP1 is 100.75 EUR with a low forecast of 69.32 EUR and a high forecast of 122.7 EUR.

What is the Revenue forecast for Arrowhead Pharmaceuticals Inc?
Projected CAGR
41%

Over the last 14 years, the compound annual growth rate for Revenue has been 77%. The projected CAGR for the next 7 years is 41%.

What is the Gross Profit forecast for Arrowhead Pharmaceuticals Inc?
Projected CAGR
43%

The compound annual growth rate for Gross Profit over the next 5 years is 43%.

Back to Top